Tempus launches first prospective cardiology study for its AI-based predictive tests
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of a multicenter study titled “Electrocardiogram-Based Artificial Intelligence-Assisted Heart Disease Detection”, or ECG-AID. The study aims to assess the impact of the company’s experimental, AI-enabled, predictive tests in cardiology and focuses on finding patients at high risk of developing atrial fibrillation …
Tempus launches first prospective cardiology study for its AI-based predictive tests Read More »